{"id":"NCT02255279","sponsor":"Novartis Vaccines","briefTitle":"Safety and Immunogenicity of an Adjuvanted Trivalent Influenza Vaccine in Children 6 to <72 Months of Age in Mexico.","officialTitle":"A Phase 3, Observed-Blind, Randomized, Multi-center Study to Evaluate Safety and Immunogenicity of an Adjuvanted Trivalent Influenza Vaccine in Children 6 to <72 Months of Age in Mexico.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-10","primaryCompletion":"2015-05","completion":"2015-05","firstPosted":"2014-10-02","resultsPosted":"2016-02-03","lastUpdate":"2017-01-27"},"enrollment":287,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"Adjuvanted Trivalent Influenza Vaccine, 1 dose for non-naive subjects (day 1), two doses for naive subjects (day 1 and day 29)","otherNames":[]},{"type":"BIOLOGICAL","name":"Non-adjuvanted Trivalent Influenza Vaccine, 1 dose for non-naive subjects (day 1), two doses for naive subjects (day 1 and day 29).","otherNames":[]}],"arms":[{"label":"aTIV","type":"EXPERIMENTAL"},{"label":"TIV","type":"ACTIVE_COMPARATOR"}],"summary":"The administration of adjuvanted Trivalent Influenza Vaccine (aTIV) has come to result in a more immunogenic and effective response compared with conventional influenza vaccines in elderly and adults.\n\nThe aim of this study is to evaluate safety and immunogenicity of Novartis aTIV in children 6 to \\<72 months of age, Mexican population, in comparison to Fluzone, a non-adjuvanted trivalent influenza vaccine (TIV).","primaryOutcome":{"measure":"Number of Naive Subjects 6 to < 36 Months Old Reporting Solicited Local and Systemic Adverse Events (AEs) From Day 1 to Day 7 Following Each Vaccination.","timeFrame":"From Day 1 to Day 7 by vaccination","effectByArm":[{"arm":"Naive_aTIV (6 to <36 Months)","deltaMin":35,"sd":null},{"arm":"Naive_TIV (6 to <36 Months)","deltaMin":20,"sd":null}],"pValues":[]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":4,"exclusionCount":14},"locations":{"siteCount":3,"countries":["Mexico"]},"refs":{"pmids":["28925801"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":77},"commonTop":["Injection site pain","Diarrhoea","Irritability","Eating disorder","Injection site erythema"]}}